123 related articles for article (PubMed ID: 26622626)
1. Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma.
Zhang SS; Tang J; Yu SY; Ma LI; Wang F; Xie SL; Jin L; Yang HY
Oncol Lett; 2015 Aug; 10(2):1063-1068. PubMed ID: 26622626
[TBL] [Abstract][Full Text] [Related]
2. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.
Hashiguchi M; Kobori H; Ritprajak P; Kamimura Y; Kozono H; Azuma M
Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10495-500. PubMed ID: 18650384
[TBL] [Abstract][Full Text] [Related]
3. The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K/Akt/mTOR pathway.
Li Z; Liu J; Que L; Tang X
J Cancer; 2019; 10(23):5770-5784. PubMed ID: 31737114
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of immune checkpoints in oral squamous cell carcinoma.
Sieviläinen M; Almahmoudi R; Al-Samadi A; Salo T; Pirinen M; Almangush A
Oral Dis; 2019 Sep; 25(6):1435-1445. PubMed ID: 30315712
[TBL] [Abstract][Full Text] [Related]
5. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 in tumors: friend or foe for tumor immunity?
Li G; Quan Y; Che F; Wang L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):245-253. PubMed ID: 29299639
[TBL] [Abstract][Full Text] [Related]
7. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.
Chen JT; Chen CH; Ku KL; Hsiao M; Chiang CP; Hsu TL; Chen MH; Wong CH
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13057-62. PubMed ID: 26438868
[TBL] [Abstract][Full Text] [Related]
9. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
[TBL] [Abstract][Full Text] [Related]
10. [Research Progress on Co-stimulating Molecule B7-H3 in Hematological Malignancies].
Zhang W; Wang J; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1758-62. PubMed ID: 26708906
[TBL] [Abstract][Full Text] [Related]
11. Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study.
Yang HY; Chu M; Zheng LW; Zwahlen RA; Luo J; Zou DH; Sun ST
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Nov; 106(5):721-8. PubMed ID: 18929994
[TBL] [Abstract][Full Text] [Related]
12. [Expression and Subcellular Distribution of Costimulatory Molecules B7-H1,B7-H3 and B7-H4 in Human Hematologic Malignancy Cell Lines].
Zhang W; Wang J; Wang YF; Zhu MX; Wan WL; Li HS; Wu FF; Yan XX; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1539-1546. PubMed ID: 27784389
[TBL] [Abstract][Full Text] [Related]
13. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.
Wang L; Cao NN; Wang S; Man HW; Li PF; Shan BE
Tumour Biol; 2016 Mar; 37(3):2961-71. PubMed ID: 26411671
[TBL] [Abstract][Full Text] [Related]
14. B7-H3 and B7-H4 expression in non-small-cell lung cancer.
Sun Y; Wang Y; Zhao J; Gu M; Giscombe R; Lefvert AK; Wang X
Lung Cancer; 2006 Aug; 53(2):143-51. PubMed ID: 16782226
[TBL] [Abstract][Full Text] [Related]
15. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
Xu YH; Zhang GB; Wang JM; Hu HC
Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
[TBL] [Abstract][Full Text] [Related]
17. Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.
Katayama A; Takahara M; Kishibe K; Nagato T; Kunibe I; Katada A; Hayashi T; Harabuchi Y
Int J Oncol; 2011 May; 38(5):1219-26. PubMed ID: 21344157
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
19. Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo.
Groeger S; Howaldt HP; Raifer H; Gattenloehner S; Chakraborty T; Meyle J
Pathol Oncol Res; 2017 Jan; 23(1):99-110. PubMed ID: 27498988
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the B7/CD28 family member B7-H3 in bladder cancer.
Wu D; Zhang Z; Pan H; Fan Y; Qu P; Zhou J
Oncol Lett; 2015 Mar; 9(3):1420-1424. PubMed ID: 25663925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
